In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary ...

In addition, patients treated with DR10624 had a 63% reduction in liver fat, which is important because many people with ...